Loading...
HE3235 Inhibits Growth of Castration-Resistant Prostate Cancer
Treatments for advanced prostate cancer (CaP) typically involve androgen deprivation therapy. However, most patients eventually develop castration-resistant CaP (CRPC) for which highly effective therapies are limited. We explored the efficacy of a novel agent, HE3235, in inhibiting growth of CRPC in...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Neoplasia Press Inc.
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2767223/ https://ncbi.nlm.nih.gov/pubmed/19881957 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|